Novo Nordisk A/S (NYSE:NVO) Upgraded at Kepler Capital Markets
Kepler Capital Markets upgraded shares of Novo Nordisk A/S (NYSE:NVO – Free Report) from a hold rating to a buy rating in a research report sent to investors on Thursday morning, Marketbeat.com reports. NVO has been the topic of several other research reports. Sanford C. Bernstein upgraded shares of Novo Nordisk A/S from an “underperform” […]
